Cargando…
Insights into the prognosis of lipidomic dysregulation for death risk in patients with coronary artery disease
BACKGROUND: Dyslipidaemia contributes to the progression of coronary artery disease (CAD) toward adverse outcomes. Plasma lipidomic measure may improve the prognostic performances of clinical endpoints of CAD. Our research is designed to identify the correlations between plasma lipid species and the...
Autores principales: | Qin, Min, Zhu, Qian, Lai, Weihua, Ma, Qilin, Liu, Chen, Chen, Xiaoping, Zhang, Yuelin, Wang, Zixian, Chen, Hui, Yan, Hong, Lei, Heping, Zhang, Shuyao, Dong, Xuekui, Wang, Hong, Huang, Min, Lian, Qizhou, Zhong, Shilong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522592/ https://www.ncbi.nlm.nih.gov/pubmed/32997403 http://dx.doi.org/10.1002/ctm2.189 |
Ejemplares similares
-
Associations of Mitochondrial Variants With Lipidomic Traits in a Chinese Cohort With Coronary Artery Disease
por: Wang, Zixian, et al.
Publicado: (2021) -
Comprehensive Metabolomics Identified the Prominent Role of Glycerophospholipid Metabolism in Coronary Artery Disease Progression
por: Chen, Hui, et al.
Publicado: (2021) -
Genome‐wide association study of metabolites in patients with coronary artery disease identified novel metabolite quantitative trait loci
por: Wang, Zixian, et al.
Publicado: (2021) -
Plasma metabolomics provides new insights into the relationship between metabolites and outcomes and left ventricular remodeling of coronary artery disease
por: Zhu, Qian, et al.
Publicado: (2022) -
Correction: Plasma metabolomics provides new insights into the relationship between metabolites and outcomes and left ventricular remodeling of coronary artery disease
por: Zhu, Qian, et al.
Publicado: (2022)